Men, women and risk of developing Alzheimer disease: Is there a difference?

August 28, 2017
PET scan of a human brain with Alzheimer's disease. Credit: public domain

Are female carriers of the apolipoprotein E ?4 allele, the main genetic risk factor for late-onset Alzheimer disease, at greater risk of developing the disease than men? A new article published by JAMA Neurology examines that question.

The prevalent view has been that women who carry copies of the ?4 allele of the apolipoprotein E (APOE) gene have a greater risk of developing Alzheimer than men with the same number of copies.

Arthur W. Toga, Ph.D., of the Keck School of Medicine at the University of Southern California, Los Angeles, and coauthors analyzed 27 research studies with data on nearly 58,000 participants to determine how sex and APOE genotype affect the risks for developing (MCI), which is often the transitional phase from cognitively normal aging to dementia, and Alzheimer. Participants in the studies were mostly white and between the ages of 55 and 85.

Women and men with one copy of apolipoprotein E ?4 allele did not show a difference in risk of Alzheimer from age 55 to 85 but women appeared to be at increased risk between the ages of 65 and 75 compared with men. And, while there was no difference in risk between these men and women for developing MCI between the ages of 55 and 85, women appeared to be at increased risk between the ages of 55 and 70 compared to men, according to the results.

The authors suggest reasons that might underlie these sex differences could be linked to physiologic changes associated with menopause and estrogen loss.

Limitations of the study include variability in the methods used to describe Alzheimer and MCI in the data sets.

"Collectively, our findings, along with previous work, warrant further investigation into a likely complex set of risk factors with consideration of sex-specific treatments for cognitive decline and AD [Alzheimer disease]. For example, if women are at increased risk for AD at younger ages, it is plausible that treatments for women may need to be initiated earlier, especially in those who carry an APOE ?4 allele," the authors write.

Explore further: Active lifestyle associated with less Alzheimer disease-related brain change among persons with APOE epsilon4 genotype

More information: JAMA Neurology (2017). DOI: 10.1001/jamaneurol.2017.2188

Related Stories

Active lifestyle associated with less Alzheimer disease-related brain change among persons with APOE epsilon4 genotype

January 16, 2012
A sedentary lifestyle is associated with greater cerebral amyloid deposition, which is characteristic of Alzheimer’s disease (AD), among cognitively normal individuals with the ε4 allele of the apolipoprotein E ...

Sleep disorders may increase cognitive problems particularly in those at risk for Alzheimer's

July 21, 2017
People who carry a genetic susceptibility to Alzheimer's disease appear to be at greater risk of diminished cognition from sleep-disordered breathing than those without the susceptibility, according to new research published ...

New genetic risk marker for late-life depression

November 3, 2015
One of the most powerful predictors in neuropsychiatry is the epsilon 4 (ε4) allele of the apolipoprotein gene (APOE).

Gene is marker only for mild cognitive impairment

February 12, 2013
Defying the widely held belief that a specific gene is the biggest risk factor for Alzheimer's disease, two Cornell developmental psychologists and their colleagues report that people with that gene are more likely to develop ...

Is a marker of preclinical Alzheimer's disease associated with loneliness?

November 2, 2016
A new article published online by JAMA Psychiatry used data from a study of 79 cognitively normal adults to examine whether cortical amyloid levels in the brain, a marker of preclinical Alzheimer disease, was associated with ...

No evidence of Alzheimer's disease-associated changes in adolescents carrying genetic risk factors

April 7, 2014
Two studies published in the Journal of Alzheimer's Disease indicate that some of the pathologic changes associated with Alzheimer's disease in older individuals are not apparent in young people who carry the apolipoprotein ...

Recommended for you

Personality changes don't precede clinical onset of Alzheimer's, study shows

September 21, 2017
For years, scientists and physicians have been debating whether personality and behavior changes might appear prior to the onset of Alzheimer's disease and related dementias.

Newly ID'd role of major Alzheimer's gene suggests possible therapeutic target

September 20, 2017
Nearly a quarter century ago, a genetic variant known as ApoE4 was identified as a major risk factor for Alzheimer's disease—one that increases a person's chances of developing the neurodegenerative disease by up to 12 ...

Is the Alzheimer's gene the ring leader or the sidekick?

September 15, 2017
The notorious genetic marker of Alzheimer's disease and other forms of dementia, ApoE4, may not be a lone wolf.

Potential noninvasive test for Alzheimer's disease

September 6, 2017
In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer's disease and distinguishing between different types of ...

Researchers unlock the molecular origins of Alzheimer's disease

September 6, 2017
A "twist of fate" that is minuscule even on the molecular level may cause the development of Alzheimer's disease, VCU researchers have found.

Is dementia declining among older Americans?

September 5, 2017
(HealthDay)—Here's some good news for America's seniors: The rates of Alzheimer's and other forms of dementia have dropped significantly over the last decade or so, a new study shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.